CEDAR KNOLLS, N.J.,
May 21, 2020 /PRNewswire/ -- MYOS
RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a
bionutrition company and the owner of
Fortetropin®, a proprietary bioactive
composition that helps build lean muscle, announced today that
it has partnered with GetHealthy.store ("GetHealthy"), a
Texas-based e-commerce platform
serving a network of over 1,000 anti-aging practitioners
nationwide. MYOS believes that this platform will greatly increase
the level of awareness, education of, and encourage the adoption
of, MYOS' products among medical
practitioners and their patients.
Since the launch of MYOS' Longevity Business at the
American Academy of Anti-Aging Medicine (A4M)
Conference in December
2019, MYOS' healthy aging products have been adopted by
various anti-aging medical practices across the United
States. At the forefront of MYOS Longevity is its brand,
Physician Muscle Health Formula®, which is
distributed exclusively to medical practitioners and leverages the
extensive portfolio of research behind our proprietary ingredient,
In a randomized, double blind, placebo-controlled human clinical
trial that was conducted at the University of
California, Berkeley, subjects who received a daily dose of
Fortetropin experienced an increase in the rate of muscle protein
synthesis by approximately 15% relative to subjects who received a
macronutrient-matched placebo. These results were presented
by the Principal Investigator, Dr. William
J. Evans at the International Conference on Frailty
& Sarcopenia Research in Toulouse, France in March 2020.
"We are absolutely delighted to work with
GetHealthy to leverage their cutting edge e-commerce
platform and extensive medical provider network to expand the reach
of the MYOS Physician Muscle Health Formula brand,"
commented MYOS CEO, Joseph
Mannello. "GetHealthy has a unique platform that
enables physicians to educate patients about the specific
nutritional supplements that best meet their medical needs.
Facilitating dialogue between patients and their medical providers
offers improved overall outcomes and compliance in terms of dosing
and consuming the right nutritional supplements," added Mr.
"We are very excited about working with MYOS to make MYOS
Physician Muscle Health Formula available to our nationwide
network of medical providers. We are very impressed by the
extensive human clinical research behind Fortetropin®
and know this research will be well received by our practitioners.
We are eager to provide access through our Get Healthy Network to
practitioners nationwide," commented Jon
Armstrong, Founder and CEO, GetHealthy.store.
About MYOS RENS Technology Inc.
MYOS RENS Technology
Inc. (MYOS), "The Muscle Company®", is a Cedar Knolls, NJ-based advanced nutrition
company that develops and markets products that improve muscle
health and performance. MYOS is the owner of
Fortetropin®, a fertilized egg yolk-based product
manufactured via a proprietary process to retain and optimize its
biological activity. Fortetropin has been clinically shown to
increase muscle size, lean body mass and reduce muscle atrophy.
MYOS believes Fortetropin has the potential to redefine existing
standards of physical health and wellness. For more information,
please visit www.myosrens.com.
GetHealthy.store is the revenue
growth platform that provides integrated eCommerce and marketing to
next-generation healthcare practitioners. GetHealthy provides a
practice-owned eCommerce store, access to multiple categories of
health products, integrated marketing technology and services, and
private label management to practices that want to engage with
their patients and followers more deeply.
Any statements in
this release that are not historical facts are forward-looking
statements. Actual results may differ materially from those
projected or implied in any forward-looking statements. Such
statements involve risks and uncertainties, including but not
limited to those relating to product and customer demand, market
acceptance of our products, the ability to create new products
through research and development, the successful results of
strategic initiatives, the success of our products,
including MYOS' Physician Muscle Health
Formula®, Yolked®, MYOS Canine
Muscle Formula®, Qurr®, and MYOS
Enteral Nutrition Formula™, the success of our
research and development, the results of the clinical evaluation
of Fortetropin® and its effects, the
ability to enter into new partnership opportunities such as the one
described in this release and the success of our existing
partnerships, the ability to enter into new distribution
agreements, the ability to generate revenue and cash flow from
sales of our products, the ability to increase our revenue and
gross profit margins, the ability to achieve a sustainable,
profitable business, the effect of economic conditions, the ability
to protect our intellectual property rights, competition from other
providers and products, the continued listing of our securities on
the Nasdaq Stock Market, risks in product development, our
ability to raise capital to fund continuing operations, the adverse
impact of the COVID-19 pandemic on the economy and our business,
and other factors discussed from time to time in our filings
with the Securities and Exchange Commission. We undertake no
obligation to update or revise any forward-looking statement for
events or circumstances after the date on which such statement is
made except as required by law.
These statements have not been evaluated by the Food and Drug
Administration. Our products are not intended to diagnose, treat,
cure or prevent any disease.
MYOS RENS Technology
View original content to download
SOURCE MYOS RENS Technology